Immune Modulation in a Randomized Trial of Neoadjuvant IRX-2 Regimen in Patients with Stage II-IV Squamous Cell Carcinoma (SCC) of the Oral Cavity. INSPIRE Trial (NCT 02609386) Interim Analysis.
2020
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI